Paychex (PAYX)

Purchases of Investments

-$5.07B

Quarterly · Period ending: · USD

PAYX logo

PAYX Purchases of Investments

Latest reported-$5.07B
PAYX Quarterly Purchases of Investments (-$5.40M → -$5.07B)
High-resolution chart · PNG

PAYX purchases of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Paychex Purchases of Investments — Quarterly (USD)
Period endingPurchases of Investments (USD)
-5,072,200,000
-1,526,800,000
-4,171,500,000
-2,796,000,000
-3,731,900,000
-5,829,700,000
-3,304,700,000
-4,093,700,000
-1,074,800,000
-861,100,000
-2,703,700,000
-1,380,200,000
-1,923,500,000
-1,992,900,000
-6,087,500,000
-2,731,100,000
-3,807,600,000
-10,357,600,000
-5,560,300,000
-1,642,300,000
-247,500,000
-1,143,200,000
-731,100,000
-1,739,900,000
-2,475,500,000
-3,365,500,000
-8,314,800,000
-5,248,500,000
-8,289,300,000
-8,898,200,000
-4,998,800,000
-10,133,000,000
-11,115,800,000
-13,798,000,000
-16,097,900,000
-11,677,600,000
-8,646,700,000
-14,432,800,000
-12,365,400,000
-8,887,100,000
-14,777,000,000
-9,871,300,000
-159,900,000
-178,100,000
-2,362,900,000
-10,475,500,000
-3,095,200,000
-10,988,700,000
-9,461,000,000
-8,687,100,000
-6,221,700,000
-8,568,900,000
-6,372,800,000
-9,677,700,000
-6,432,800,000
-6,993,700,000
-5,228,600,000
-2,544,300,000
-2,905,600,000
-3,077,100,000
-1,653,500,000
-1,467,700,000
-847,900,000
-1,955,100,000
-1,958,400,000
-287,292,000
-510,832,000
-420,271,000
-336,555,000
1,448,450,000
-1,529,572,000
-3,144,069,000
-13,140,530,000
-6,149,322,000
-14,411,373,000
-26,640,097,000
-33,300,803,000
-29,672,611,000
-29,820,156,000
-25,496,257,000
-24,653,461,000
-24,530,768,000
-64,835,357,000
-1,368,520,000
-337,797,000
-2,646,658,000
-304,539,000
-112,058,000
-167,277,000
-316,864,000
-311,198,000
-369,129,000
-239,817,000
-207,929,000
-187,963,000
-203,430,000
-216,392,000
-359,204,000
-319,225,000
-218,889,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.